\thispagestyle {empty}
\contentsline {chapter}{\numberline {1}Review of computational drug repositioning approaches}{11}{chapter.1}
\contentsline {section}{\numberline {1.1}Relevance of drug repositioning}{12}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Opportunities for finding new indications}{13}{subsection.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}Drug repositioning faces legal and scientific challenges}{16}{subsection.1.1.2}
\contentsline {section}{\numberline {1.2}Drug repositioning and indication discovery: Success stories}{17}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Sildenafil: Repositioning from clinical side-effects}{18}{subsection.1.2.1}
\contentsline {subsection}{\numberline {1.2.2}Thalidomide: Repositioning a hazardous drug}{19}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}Raloxifene: Expanding the application line}{20}{subsection.1.2.3}
\contentsline {section}{\numberline {1.3}Computational approaches towards drug repositioning}{21}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}Chemical structure-based approaches}{22}{subsection.1.3.1}
\contentsline {subsection}{\numberline {1.3.2}Gene expression and functional genomics-based approaches}{25}{subsection.1.3.2}
\contentsline {subsection}{\numberline {1.3.3}Protein structure and molecular docking-based approaches}{28}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Phenotype and side-effect-based approaches}{30}{subsection.1.3.4}
\contentsline {subsection}{\numberline {1.3.5}Genetic variation-based approaches}{33}{subsection.1.3.5}
\contentsline {subsection}{\numberline {1.3.6}Disease network-based approaches}{35}{subsection.1.3.6}
\contentsline {subsection}{\numberline {1.3.7}Machine learning and concepts combination approaches}{37}{subsection.1.3.7}
\contentsline {subsection}{\numberline {1.3.8}Summary}{39}{subsection.1.3.8}
\contentsline {section}{\numberline {1.4}Thesis: Biological process and molecular function for drug repositioning}{42}{section.1.4}
\contentsline {subsection}{\numberline {1.4.1}Rationale}{43}{subsection.1.4.1}
\contentsline {subsection}{\numberline {1.4.2}Towards the specification, implementation and analysis}{45}{subsection.1.4.2}
\contentsline {subsubsection}{\numberline {1.4.2.1}Chapter 2 - Description logics and biomedical knowledge (Specification)}{46}{subsubsection.1.4.2.1}
\contentsline {subsubsection}{\numberline {1.4.2.2}Chapter 3 - The Functional Therapeutic Chemical Classification System (Implementation)}{46}{subsubsection.1.4.2.2}
\contentsline {subsubsection}{\numberline {1.4.2.3}Chapter 4 - Systematic drug repositioning analysis}{46}{subsubsection.1.4.2.3}
\contentsline {subsubsection}{\numberline {1.4.2.4}Chapter 5 - Outlook}{47}{subsubsection.1.4.2.4}
\contentsline {chapter}{\numberline {2}Description logics and biomedical knowledge }{49}{chapter.2}
\contentsline {section}{\numberline {2.1}Biomedical knowledge}{50}{section.2.1}
\contentsline {subsection}{\numberline {2.1.1}Formalisation in biomedical sciences}{50}{subsection.2.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.1}Formalism varies among natural sciences}{50}{subsubsection.2.1.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.2}Organisms as complex machines}{51}{subsubsection.2.1.1.2}
\contentsline {subsection}{\numberline {2.1.2}Requirements for biomedical knowledge formalisation}{51}{subsection.2.1.2}
\contentsline {section}{\numberline {2.2}Description logics for biomedical knowledge}{52}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Problem addressed}{53}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Expressivity and complexity}{55}{subsection.2.2.2}
\contentsline {chapter}{Bibliography}{63}{chapter*.18}
\contentsline {chapter}{\numberline {A}Extra Information}{65}{appendix.A}
